Merck & Co., Inc (MRK)

Exchange: New York Stock Exchange
Currency: USD

 
Price: 82.26 (Close)

Summary

 

52 Week range 200d Moving Avg. Beta
65.25 – 92.64 83.20 0.70
Dividend Dividend Yield Ex-Dividend date
2.32 2.84% 2020-03-13
P/E Ratio Latest EPS DGR 3 years
20.69 2.32 6.90%
Near Fair Value
Low
Low Volatility
High
Slow
Dividend Growth
Fast

Profile

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company’s relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

 

Sector: Industry:
Health Technology Pharmaceuticals: Major

Environment, Social and Governance (ESG) Ratings

Total ESG Score

29 – 48 percentile

Environment

3 – 4 percentile

Social

14 – 4 percentile

Governance

15 – 4 percentile

Controversy level

3


Dividend Safety Metrics

Latest EPS 2.32
Annual Payout 2.32
Payout Ratio 100.00%
Dividend growth Years
Dividend Score 67
Dividend Coverage Ratio 1.54
Altman-Z score 0.00

 

Merck & Co., Inc (MRK) Valuation


Merck & Co., Inc’s current dividend yield of 2.84% is -5% below its 5-year average. The 5-year average dividend yield is 3.00% (see red-line in chart). This indicates the stock looks reasonably valued today.

Merck & Co., Inc (MRK) Performance

The chart below displays the total price return(%) of Merck & Co., Inc for different periods:

 

Merck & Co., Inc (MRK) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Merck & Co., Inc for different periods:

 


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
2.84 2.32 100.00% Years

 

Dividend Growth Summary

3 Year Growth Rate (CAGR) 6.90%
5 Year Growth Rate (CAGR) 5.01%
10 Year Growth Rate (CAGR) 4.05%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2020 1.220 -%
2019 2.260 13.6%
2018 1.990 5.3%
2017 1.890 2.2%
2016 1.850 2.2%
2015 1.810 2.3%
2014 1.770 2.3%
2013 1.730 2.4%
2012 1.690 8.3%
2011 1.560 2.6%
2010 1.520 0.0%
2009 1.520 0.0%
2008 1.520 0.0%
2007 1.520 0.0%
2006 1.520 0.0%
2005 1.520 1.3%

Merck & Co., Inc (MRK) Dividend Payment History